NEW YORK, June 14, 2016 /PRNewswire/ -- AccentHealth, the leading patient education media company at the point of care, announced today that it has purchased PageScience (formerly Precision Health Media), a pioneer in programmatic advertising targeting for pharmaceutical marketers. With the acquisition, AccentHealth's patient engagement platform can now provide health and wellness marketers multiple, unique touchpoints across the patient journey.
In the past, regulatory and privacy concerns have delayed many pharmaceutical brands from utilizing programmatic advertising, a $20 billion market that is experiencing exponential growth. However, contextual page-level targeting, that focuses message placement based on very specific criteria is reshaping the digital pharma landscape.
"PageScience's innovative PageMatch™ technology has given healthcare marketers a safe and effective way to embrace programmatic advertising," said Dan Stone, CEO, AccentHealth. "AccentHealth has strengthened its ability to reach patients, when and where they are most engaged and receptive to health messages."
The PageMatch technology analyzes and scores more than 100 million pages per week to deliver branded healthcare advertisements on more than 1,100 premium content websites based on the contextual relevancy of the page. This proprietary technology provides healthcare marketers with a highly effective way to leverage programmatic buying technology while ensuring that no cookies are used for user retargeting, a key requirement for some pharmaceutical marketers to satisfy privacy concerns.
"Over the last eighteen months we have seen impressive uptake from the healthcare industry, which speaks to the value of targeting messages based on highly specific content criteria," said Bill Jennings, CEO, PageScience. "AccentHealth and PageScience's capabilities both center on reaching people when they are most focused on their health. Joining forces made a lot of sense, and my colleagues and I are delighted to become part of the AccentHealth team."
Mr. Jennings will become president of the PageScience division of AccentHealth, and together with the balance of the PageScience team, join AccentHealth's New York City office.
New York-based PageScience, formerly Precision Health Media, delivers vast reach and precise page-level targeting to brands. The company is backed by Metamorphic Ventures, Cava Capital, Hub Angels and several individual investors including Mike Perlis (CEO Forbes), Rick Thompson/Larry Braitman (Founders Adify, Flycast), Joe Apprendi (Founder Collective), Richard Forman (Health Venture Group), Geoff Judge (Partner iNovia), Bill Benedict (Alpine Meridian), Chris Young (Founder Digital Broadcasting Group). PageMatch is a trademark of PageScience. For more information, visit www.pagescience.com.
About AccentHealth, LLC
AccentHealth is the most trusted patient education media company at the point-of-care, located in 30,000 physician offices, utilized by 90,000 healthcare practitioners and serving 375MM annual patients visits. AccentHealth's mission is to inspire patients to live healthier lives to drive positive healthcare outcomes. AccentHealth's Patient Engagement Platform combines innovative, award-winning digital products including the leading waiting room television network, interactive tablets for the exam room, and mobile touchpoints. AccentHealth's world class content is produced by CNN's Medical Unit, hosted by Dr. Sanjay Gupta, and by Harvard Medical School. Founded in 1995, AccentHealth is based in New York City and Tampa, FL and is owned by M/C Partners, Ridgemont Equity Partners and senior management. AccentHealth is a founding member of the Point-of-Care Communication Council (PoC3).
For more information, visit www.accenthealth.com.
Continuum Health Communications
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/leading-point-of-care-media-company-accenthealth-acquires-programmatic-health-platform-pioneer-pagescience-300284052.html